Article | February 16, 2022

Mitigate Risk By Being Courier Agnostic

By Gregory Stevens, Executive Director - Business Operations, Cryoport Systems

GettyImages-1194340512-green-supply-chain-logistics-transportation-environment

Among the many challenges COVID-19 has brought to light in all walks of life; formidable challenges abound with shipping critical, high value, temperature sensitive materials. And as expected, some logistic couriers are flourishing while others are floundering. The impact on key stakeholders, especially within cell and gene therapy, has been profound. The loss of critical and often irreplaceable material can be devastating; clinical programs can fail and worse yet, the outcome for immunocompromised patients can be lethal.

Cryoport Systems has grown leaps and bounds during the pandemic due to our ability to mitigate risk. One of the fundamental ways we accomplish this is by being courier agnostic. In short, we are not tied to any courier. Rather, we partner with over 30 different couriers.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene